BioStock: Evaxion Biotech Secures Equity Financing of up to 40 MUSD

Report this content

Evaxion’s use of artificial intelligence platforms to develop new cancer drugs has caught the eye Lincoln Park Capital, a Chicago-based asset management firm. The Danish biotech has announced an agreement with the firm, securing access to up to 40 MUSD.

Read the full article about Evaxion at biostock.se:

https://www.biostock.se/en/2022/06/evaxion-biotech-secures-equity-financing-of-up-to-40-musd/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Subscribe

Documents & Links

Quick facts

BioStock: Evaxion Biotech Secures Equity Financing of up to 40 MUSD
Tweet this